Analyst Ratings for Nabriva Therapeutics AG (NBRV)
Overall Rating:
NEUTRAL
Rating Trend:
=
Avg. $ Target:
N/A
Rating Score: 3.6 / 10
Percentile Rank: 34%
Rating Score: 3.6 / 10
Percentile Rank: 34%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 1/6/2023 | Northland | Carl Byrnes | Downgrade | Underperform (Outperform) |
1.00 (8.00) |
2.36 (1.42) |
-39.83% | Details |
| 7/8/2021 | Jefferies | Eun Yang | New Coverage | Hold (N/A) |
1.35 (N/A) |
1.27 (1.42) |
11.81% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
